依福地平
|
|
|
- CAS号:
- 111011-76-8
- 英文名:
- EFONIDIPINE
- 英文别名:
- nz-105;nz105ethanolate;Hydrochloride ethanol;EFONIDIPINE USP/EP/BP;r,p-oxide,monohydrochloride;efonidipinehydrochlorideethanolate;NZ-105 HYDROCHLORIDE MONOETHANOLATE;2-(phenyl(phenylmethyl)amino)ethyleste;Efonidipine hydrochloride monoethanolate;Efonidipine Hydrochloride ethanol (1:1:1)
- 中文名:
- 依福地平
- 中文别名:
- 依福地平;盐酸依福地平;依福地平杂质;依福地平杂质C;盐酸依福地平乙醇盐;盐酸依福地平一水合物;盐酸依福地平一乙醇盐;2-(苄基(苯基)氨基)乙基 5-(5,5-二甲基-2-氧化-1,3,2-二氧膦杂环己烷-2-基)-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3-羧酸酯乙醇络合物盐酸盐;2-(苄基(苯基)氨基)乙基 5-(5,5-二甲基-2-氧化-1,3,2-二氧膦杂环己烷-2-基)-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3-羧酸酯乙醇络合物盐酸盐(1:1:1)
- CBNumber:
- CB9317820
- 分子式:
- C34H38N3O7P.C2H6O.ClH
- 分子量:
- 714.19
- MOL File:
- 111011-76-8.mol
|
|
|
依福地平化学性质
-
熔点:
-
151° (dec)
-
|
-
储存条件:
-
Inert atmosphere,2-8°C
-
|
-
溶解度:
-
DMSO : 25 mg/mL (35.01 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
-
|
-
形态:
-
Powder
-
|
-
颜色:
-
Light yellow to yellow
-
|
依福地平性质、用途与生产工艺
Efonidipine hydrochloride monoethanolate (NZ-105 hydrochloride monoethanolate) 是T型和L型钙离子通道双重阻断剂。
依福地平
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/11/08 | HY-12502A | Efonidipine hydrochloride monoethanolate | | 5 mg | 500元 |
| 2024/11/08 | HY-12502A | 依福地平
Efonidipine hydrochloride monoethanolate | 111011-76-8 | 10mg | 800元 |
依福地平
生产厂家
全球有 90家供应商
依福地平国内生产厂家
111011-76-8, 依福地平 相关搜索:
- 抑制剂
- 药靶配体
- 原料药
- 化学试剂
- 试剂
- C34H38N3O7PHClC2H5OH
- C34H38N3O7P
- 2-(苄基(苯基)氨基)乙基 5-(5,5-二甲基-2-氧化-1,3,2-二氧膦杂环己烷-2-基)-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3-羧酸酯乙醇络合物盐酸盐
- 盐酸依福地平乙醇盐
- 盐酸依福地平一水合物
- 2-(苄基(苯基)氨基)乙基 5-(5,5-二甲基-2-氧化-1,3,2-二氧膦杂环己烷-2-基)-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3-羧酸酯乙醇络合物盐酸盐(1:1:1)
- 盐酸依福地平一乙醇盐
- 依福地平
- 盐酸依福地平
- 依福地平杂质
- 依福地平杂质C
- 111011-76-8
- 3-Pyridinecarboxylic acid, 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[phenyl(phenylmethyl)amino]ethyl ester, hydrochloride, compd. with ethanol (1:1:1)
- inhibit,Efonidipine hydrochloride monoethanolate,Ca channels,Ca2+ channels,Calcium Channel,Inhibitor
- 2-(Benzyl(phenyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate ethanol hydrochloride
- 2-(Benzyl(phenyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate compound with ethanol (1:1) hydrochloride
- Ethanol, compd. with 2-(phenyl(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate P-oxide monohydrochloride (1:1)
- EFONIDIPINE USP/EP/BP
- NZ-105 HYDROCHLORIDE MONOETHANOLATE
- Hydrochloride ethanol
- 5-(5,5-Dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylicacid2-[phenyl(phenylmethyl)amino]ethylesterhydrochloridemonoethanolate
- r,p-oxide,monohydrochloride
- nz105ethanolate
- nz-105
- efonidipinehydrochlorideethanolate
- 3-pyridinecarboxylicacid,1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-1,3,2-dioxa
- 2-(phenyl(phenylmethyl)amino)ethyleste
- Efonidipine Hydrochloride ethanol (1:1:1)
- Efonidipine hydrochloride monoethanolate